Permeability changes in blood-retinal barrier of galactosemic rats are prevented by aldose reductase inhibitors

S. Lightman, E. Rechthand, H. Terubayashi, A. Palestine, S. Rapoport, P. Kador

Research output: Contribution to journalArticle

32 Scopus citations

Abstract

Permeability-surface-area products (PA) for sucrose at the blood-retinal barrier (BRB) were determined with quantitative in vivo techniques and compared in control rats, rats fed a 50% galactosemic diet, and rats fed a diet containing both galactose and the aldose reductase inhibitor sorbinil. The mean PA ± SE for controls was 0.656 x 10-5 ± 0.13 ml·g-1·s-1 and increased by ~500% in galactose-fed animals to 3.13 x 10-5 ± 0.32 ml·g-1·s-1. Animals fed both galactose and sorbinil showed no significant difference from control animals (P > .05), with a PA of 0.91 x 10-5 ± 0.22 ml·g-1·s-1. No breach in the BRB to horseradish peroxidase was detected in any of the groups. These results demonstrate an increased permeability at the BRB to small molecules in galactosemic rats that is prevented by an aldose reductase inhibitor. This suggests that the retinal capillary basement membrane thickening seen in galactosemic rats is associated with an increased permeability of the BRB and that aldose reductase is implicated in its pathogenesis.

Original languageEnglish (US)
Pages (from-to)1271-1275
Number of pages5
JournalDiabetes
Volume36
Issue number11
DOIs
Publication statusPublished - Jan 1 1987

    Fingerprint

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this